{"id":"W1995931600","doi":"10.1016/j.bbmt.2014.02.021","title":"Survival Improvements in Adolescents and Young Adults after Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; Therakos; Sigma-Tau Pharmaceuticals; Kiadis Pharma; Genentech; CellGenix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Blue Cross and Blue Shield Association; Swedish Orphan Biovitrum; Amgen; Otsuka America Pharmaceutical; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; Otsuka America; U.S. Navy; Osiris Therapeutics; Celgene; Ariad Pharmaceuticals; GlaxoSmithKline; U.S. Department of Defense; Sanofi; Be The Match Foundation","keywords":"Medicine; Young adult; Transplantation; Lymphoblastic Leukemia; Pediatrics; Hematopoietic stem cell transplantation; Survival rate; Hematopoietic cell; Survival analysis; Acute lymphocytic leukemia; Leukemia; Internal medicine; Haematopoiesis; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003963465,0.00009184515,0.0001730021,0.0004263623,0.0002113452,0.0003226422,0.0001000378,0.0001972508,0.0006504094],"category_scores_gemma":[0.001457433,0.00006761242,0.0002064286,0.0004394127,0.0001556965,0.0003392488,0.0002899548,0.000330182,0.00009975513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002838084,"about_ca_system_score_gemma":0.0002743286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003472154,"about_ca_topic_score_gemma":0.007889603,"domain_scores_codex":[0.9998052,0.0000511903,0.00002302848,0.00003332062,0.00002912055,0.0000582823],"domain_scores_gemma":[0.9991933,0.0001165678,0.0004466569,0.000023266,0.00006888388,0.0001514163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001142359,0.0000207517,0.9960692,0.000006090494,0.00001784679,0.0000567701,0.00009799617,0.00002485238,0.0001245244,0.0000165363,0.00009038115,0.003360853],"study_design_scores_gemma":[0.000006544869,0.0001668433,0.9989759,0.000008453132,0.00001568853,0.0001669719,0.0002566721,0.00004650123,0.00005787414,0.00001721297,0.0002800631,0.00000130727],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993966,0.0002873085,0.00001867892,0.0000309189,0.000003562069,0.000002138293,0.0001205849,8.779888e-7,0.0001393795],"genre_scores_gemma":[0.9993536,0.0002368656,0.00003108918,0.00003867473,0.000009503117,0.000005131048,0.0002534471,5.23576e-7,0.00007120083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003472154,"threshold_uncertainty_score":0.006903887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007041638665362928,"score_gpt":0.2560707309120256,"score_spread":0.2490290922466627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}